For the many people around the globe who suffer from asthma, scientists may have just made a very important discovery. An early study published in a medical journal suggests that a drug called Fevipiprant could do wonders to reduce inflammation in the airways of asthma patients.

Today, asthma sufferers are relying on inhalers to treat asthma, which affects the airways in the lungs and results in feelings of breathlessness as well as coughing and wheezing. Inhalers can help control it, but it’s not enough for many people who have to deal with the ailment.

And it’s not a small problem. According to a BBC report, 1,216 people died from asthma in 2014 in the UK.

This study looked at 60 patients who had severe cases of asthma even with inhalers, and had to have treatment from specialists. Half of them were given Fevipiprant for three months in addition to usual medications, and the other half simply continued with their medications. Those who took Fevipiprant had fewer inflammatory blood cells in their airways, the study found.